NEW YORK, Feb. 5, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
New markets in clinical diagnoses and clinical studies are emerging as prices decrease and technology creates more advanced devices. Smart phones include the technology to implement a core device used for m-health implementations. Unit functions are being extended from direct arrhythmia symptom analysis to sleep studies and clinical drug efficacy studies creating significant growth opportunity.According to Susan Eustis, lead author of the WinterGreen Research team that prepared the cardiac event ambulatory monitors and recorders market research study, "Shortness of breath is a common symptom of cardiac disease. It is frequently misdiagnosed as a respiratory symptom or ignored by patients and is not even considered a cardiac symptom when the clinician is making a diagnosis. Cardiac event ambulatory monitors can detect arrhythmias and get people to treatment faster before it is too late to correct congestive heart failure." Early treatment is essential and the technology is a vital aid in providing that treatment. Hospitals and clinicians will have increased access to devices as insurers realize the value of detecting and treating cardiac disease early. Sleep studies and clinical drug efficacy study opportunities are creating significant growth opportunity. Cardiac Event Recording and monitors are evolving as a services industry. Patients do not pay directly for units, they are provided by a clinician and the clinician is reimbursed by CMS in the US as a fee for service. In this manner the vendors participate in the services market. The cardiac event recording services industry is fragmented and characterized by a large number of smaller regional hospital and home care service providers.